Literature DB >> 7035953

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.

.   

Abstract

In a prospective, controlled study, 50 children with frequently relapsing nephrotic syndrome who had steroid toxicity were treated for eight weeks with either cyclophosphamide (2 mg per kilogram of body weight per day) or chlorambucil (0.15 mg per kilogram per day), in combination with prednisone in tapering doses. Of the 34 children shows relapses had tended to occur after the prednisone dosage had been reduced or immediately after the drug was discontinued (the steroid-dependent group), 22 also had early relapses after cytotoxic-drug treatment. In contrast, cytotoxic drug treatment produced long-lasting remissions in 12 of the 16 children whose relapses usually occurred after prednisone treatment had been interrupted for more than 14 days (the non-steroid-dependent group). The difference in response between the two groups was highly significant (P less than 0.001). We conclude that patients with frequent relapses without steroid dependence can be treated successfully with an eight-week course of cytotoxic drugs, whereas those with steroid-dependent nephrotic syndrome do not profit from cytotoxic drugs in the low doses used.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035953     DOI: 10.1056/NEJM198202253060803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  36 in total

Review 1.  Evidence-based management of steroid-sensitive nephrotic syndrome.

Authors:  Elisabeth M Hodson; Jonathan C Craig; Narelle S Willis
Journal:  Pediatr Nephrol       Date:  2005-06-21       Impact factor: 3.714

2.  The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1.

Authors:  Udo Vester; Birgitta Kranz; Stephanie Zimmermann; Rainer Büscher; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

Review 3.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2015-03-18

Review 4.  Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Authors:  Rebecca M Lombel; Debbie S Gipson; Elisabeth M Hodson
Journal:  Pediatr Nephrol       Date:  2012-10-03       Impact factor: 3.714

5.  In what order should one introduce cyclophosphamide or chlorambucil, cyclosporine or levamisole in a child with steroid-dependent frequently relapsing nephrotic syndrome?

Authors:  J Brodehl
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 6.  Immunosuppressive therapy in the nephrotic syndrome in children.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

Review 7.  Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?

Authors:  Jörg Dötsch; Dirk E Müller-Wiefel; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

8.  [Drug treatment of chronic glomerulonephritis: pro].

Authors:  K Kühn; J Brodehl; K M Koch; U Helmchen
Journal:  Klin Wochenschr       Date:  1985-09-16

9.  Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  J Brodehl; M Brandis; U Helmchen; P F Hoyer; R Burghard; J H Ehrich; R B Zimmerhackl; W Klein; K Wonigeit
Journal:  Klin Wochenschr       Date:  1988-11-15

10.  Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  P Niaudet
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.